Luoxin Pharmaceuticals Group Stock received a regulatory letter from the Shenzhen Stock Exchange for violations including inaccurate revenue disclosure, incomplete disclosure of important contract terms, and failure to review and disclose some related party transactions. The company's chairman Liu Zhenteng, general manager Liu Baoqi, CFO Chen Xian, and secretary of the board of directors Han Fengsheng failed to fulfill their duties and ethical obligations, violated relevant rules of the Shenzhen Stock Exchange, and are responsible for the above violations. The company and all directors, supervisors, and senior management personnel are reminded to strictly comply with the Securities Law, Company Law, relevant laws and regulations, as well as the Shenzhen Stock Exchange's Rules for the Listing of Stocks and related regulations, and to fulfill their information disclosure obligations in a truthful, accurate, complete, timely, and fair manner, in order to prevent such incidents from happening.